Safety and side effects of the insulin analogues [2]

Expert Opinion on Drug Safety

Volumn 5, Issue 2, 2006, Pages 195-196

  González, Claudio D ^a   Di Girolamo, Guillermo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN SENSITIZING AGENT; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE;

CLINICAL PROTOCOL; CLINICAL TRIAL; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG INDICATION; DRUG POTENTIATION; DRUG SAFETY; EDEMA; HEART FAILURE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MEDICAL RECORD; META ANALYSIS; METHODOLOGY; MONOTHERAPY; PHARMACODYNAMICS; PREGNANCY DIABETES MELLITUS; SYSTEMATIC REVIEW; DIABETES MELLITUS; NOTE; REPRODUCIBILITY; SAFETY;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; REPRODUCIBILITY OF RESULTS; SAFETY;

EID: 33644908758     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.5.2.195     Document Type: Letter

References (4)

1. KAMAL AD, DIXON AN, BAIN SC: Safety and side effects of the insulin analgues. Expert Opin. Drug Saf. (2006) 5(1):131-143.
2. SIEBENHOFER A, PLANK J, PIEBER TR: Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst. Rev. (2004):CD003287.
3. SCHOOFF M, EHLERS K: Short-acting insulin analogues vs. human insulin for diabetes. Am. Fam. Physician (2005) 72(5):805-807.
4. GONZALEZ C, SANTORO S, SALZBERG S et al.: Insulin analogue therapy in pregnancies complicated by diabetes mellitus. Expert Opin. Pharmacother. (2005) 6(5):735-742.